HSR Act waiting period terminated for United Therapeutics’ acquisition of SteadyMed Ltd.
United Therapeutics and SteadyMed announced the termination of the waiting period under the Hart-Scott-Rodino Antitrust Act relating to United Therapeutics' previously announced acquisition of SteadyMed. The transaction is expected to close in the second half of 2018. July 20, 2018